PT Metro Healthcare Indonesia Tbk (ISX:CARE) Total Operating Expense: Rp146,859 Mil (TTM As of Mar. 2026)


ISX:CARE PT Metro Healthcare Indonesia Tbk ISX:CARE
79 GF Score
Price Rp426.00
GF Value Rp367.83
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is PT Metro Healthcare Indonesia Tbk Total Operating Expense?

PT Metro Healthcare Indonesia Tbk ISX:CARE -0.93% 79 Total Operating Expense is Rp146,859 Mil as of Mar. 2026. GuruFocus rates ISX:CARE with a GF Score™ of 79/100 and a GF Value™ of Rp367.83 (Modestly Overvalued). The stock has 2 warning signs investors should review.

PT Metro Healthcare Indonesia Tbk's Total Operating Expense for the three months ended in Mar. 2026 was Rp41,904 Mil. PT Metro Healthcare Indonesia Tbk's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was Rp146,859 Mil.

PT Metro Healthcare Indonesia Tbk Total Operating Expense Related Terms

PT Metro Healthcare Indonesia Tbk Total Operating Expense Historical Data

* Premium members only.

The historical data trend for PT Metro Healthcare Indonesia Tbk's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Metro Healthcare Indonesia Tbk Total Operating Expense Chart

PT Metro Healthcare Indonesia Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 131,835.96 156,619.73 125,410.16 133,237.21 145,120.98

PT Metro Healthcare Indonesia Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 40,166.11 20,770.87 27,867.56 56,316.44 41,903.77
ISX:CARE
79GF Score
PT Metro Healthcare Indonesia Tbk ISX:CARE
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Metro Healthcare Indonesia Tbk Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp146,859 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of Rp146,859 Mil mean?
PT Metro Healthcare Indonesia Tbk (ISX:CARE) has a Total Operating Expense of Rp146,859 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on PT Metro Healthcare Indonesia Tbk and its competitors.
Is PT Metro Healthcare Indonesia Tbk's Total Operating Expense too high?
PT Metro Healthcare Indonesia Tbk's current Total Operating Expense is Rp146,859 Mil. Overall, PT Metro Healthcare Indonesia Tbk has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Metro Healthcare Indonesia Tbk's Total Operating Expense compare to HCA and THC?
PT Metro Healthcare Indonesia Tbk's Total Operating Expense of Rp146,859 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Healthcare Providers & Services company?
A good Total Operating Expense depends on the Healthcare Providers & Services industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on PT Metro Healthcare Indonesia Tbk and its competitors. PT Metro Healthcare Indonesia Tbk's current Total Operating Expense is Rp146,859 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Metro Healthcare Indonesia Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk (ISX:CARE) is currently considered Modestly Overvalued. The stock's GF Value™ is Rp367.83, compared to a current price of Rp426.00 — trading 15.8% above its estimated fair value. The current Total Operating Expense is Rp146,859 Mil. PT Metro Healthcare Indonesia Tbk's overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For PT Metro Healthcare Indonesia Tbk (ISX:CARE), the current Total Operating Expense is Rp146,859 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Metro Healthcare Indonesia Tbk (ISX:CARE) Overvalued in 2026?

Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk stock appears to be overvalued. The current stock price of Rp426.00 is trading 15.8% above its estimated GF Value™ of Rp367.83. GuruFocus considers PT Metro Healthcare Indonesia Tbk to be Modestly Overvalued.

Key valuation signals for ISX:CARE:

  • Total Operating Expense: Rp146,859 Mil
  • GF Value™: Rp367.83 vs. price of Rp426.00 (15.8% above fair value)
  • GF Score™: 79/100 with 2 warning signs

No single metric tells the full story. See the ISX:CARE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Metro Healthcare Indonesia Tbk Business Description

Address Jalan Raya Serang Km 16,8, RT / RW 005/001, Kel. Sukamulya, Kec. Cikupa, Tangerang, IDN, 15710
PT Metro Healthcare Indonesia Tbk provides integrated health services that consist of hospital and technology-based health services and training centers to produce professionals in health services. The company manages hospitals that are members of the Metro Hospital Group. Its business segment comprises Hospital services and Investment. The majority of revenue is derived from the Hospital services segment that comprises integrated healthcare services for inpatient and outpatient.
79GF Score

Get the complete analysis for ISX:CARE

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp426.00
Price
Rp367.83
GF Value